Role of Endothelin-1 in Blood Pressure Regulation in a Rat Model of Visceral Obesity and Hypertension
ABSTRACT—Endothelial dysfunction has been suggested to play an important role in the development of obesity-induced hypertension. Because endothelin release increases in response to endothelial damage, we examined whether endothelin-1 contributes to increased arterial pressure in a model of visceral...
Gespeichert in:
Veröffentlicht in: | Hypertension (Dallas, Tex. 1979) Tex. 1979), 2004-02, Vol.43 (2, Part 2), p.383-387 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 387 |
---|---|
container_issue | 2, Part 2 |
container_start_page | 383 |
container_title | Hypertension (Dallas, Tex. 1979) |
container_volume | 43 |
creator | da Silva, Alexandre A Kuo, Jay J Tallam, Lakshmi S Hall, John E |
description | ABSTRACT—Endothelial dysfunction has been suggested to play an important role in the development of obesity-induced hypertension. Because endothelin release increases in response to endothelial damage, we examined whether endothelin-1 contributes to increased arterial pressure in a model of visceral obesity produced by feeding Sprague-Dawley rats a high-fat (HF) diet (40% fat w/w, n=6) for 12 months. Arterial and venous catheters were implanted for measurement of mean arterial pressure (MAP) and heart rate (HR) 24 hours per day and intravenous infusions. After a 5-day control period, rats were infused with the selective endothelin-1 type A receptor (ET-A) blocker ABT-627 (2.5 mg/kg per day, IV) for 9 days, followed by a recovery period. Rats fed a standard chow (normal fat, or NF, groupn=6) for 12 months were also infused with ET-A blocker and were used as controls. Compared with NF rats, HF rats had higher MAP (113±4 versus 98±2 mm Hg), increased visceral fat (18.7±2.0 versus 10.8±1.4 g), and 3.2-fold increase in plasma leptin despite similar total body weight gain. Long-term ET-A blockade markedly reduced MAP in HF (−14±3 mm Hg) and NF (−14±2 mm Hg), but it had no effect on HR, GFR, or PRA. These results indicate that a long-term HF diet may cause visceral obesity and increased MAP, even in the absence of major changes in total body weight. Endothelin-1 appears to play an important role in the maintenance of arterial pressure in rats fed HF and NF diets, but it does not appear to contribute to increased MAP in this model of diet-induced hypertension. |
doi_str_mv | 10.1161/01.HYP.0000111139.94378.74 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80128446</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80128446</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5106-dc94c2cbd1a6535665000d766d2d39bd597c7ed3388e7b597947a0627c085d6f3</originalsourceid><addsrcrecordid>eNpdkV9v0zAUxS3ExErhKyBrEntLZjv-k_AG00aRhjZVgODJcuwbmuHGxU409dvjrJUqcV-uLP-O7_E9CF1QUlIq6RWh5erXQ0ly0VxVUza8UnWp-Au0oILxggtZvUQLQhteNJT-PEevU3rMOOdcvULnlCuiqOQLBOvgAYcO3wwujBvw_VBQ3A_4kw_B4YcIKU0R8Bp-T96MfRjmS4PXZsRfgwM_a3_0yUI0Ht-3kPpxj83g8Gq_gzjCkLLmDTrrjE_w9tiX6PvtzbfrVXF3__nL9ce7wgpKZOFswy2zraNGikpIKfIXnZLSMVc1rRONsgpcVdU1qDafGq4MkUxZUgsnu2qJLg_v7mL4O0Ea9Xa25r0ZIExJ14SymnOZwYv_wMcwxSF704wIpmqW97pEHw6QjSGlCJ3exX5r4l5TouckNKE6J6FPSejnJLTiWfzuOGFqt-BO0uPqM_D-CJhkje-iGWyfTpwQtSJydsEP3FPwI8T0x09PEPUGjB83z6M5k3XBcieMUFLMZmT1D06Hn08</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205278211</pqid></control><display><type>article</type><title>Role of Endothelin-1 in Blood Pressure Regulation in a Rat Model of Visceral Obesity and Hypertension</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Journals@Ovid Complete</source><creator>da Silva, Alexandre A ; Kuo, Jay J ; Tallam, Lakshmi S ; Hall, John E</creator><creatorcontrib>da Silva, Alexandre A ; Kuo, Jay J ; Tallam, Lakshmi S ; Hall, John E</creatorcontrib><description>ABSTRACT—Endothelial dysfunction has been suggested to play an important role in the development of obesity-induced hypertension. Because endothelin release increases in response to endothelial damage, we examined whether endothelin-1 contributes to increased arterial pressure in a model of visceral obesity produced by feeding Sprague-Dawley rats a high-fat (HF) diet (40% fat w/w, n=6) for 12 months. Arterial and venous catheters were implanted for measurement of mean arterial pressure (MAP) and heart rate (HR) 24 hours per day and intravenous infusions. After a 5-day control period, rats were infused with the selective endothelin-1 type A receptor (ET-A) blocker ABT-627 (2.5 mg/kg per day, IV) for 9 days, followed by a recovery period. Rats fed a standard chow (normal fat, or NF, groupn=6) for 12 months were also infused with ET-A blocker and were used as controls. Compared with NF rats, HF rats had higher MAP (113±4 versus 98±2 mm Hg), increased visceral fat (18.7±2.0 versus 10.8±1.4 g), and 3.2-fold increase in plasma leptin despite similar total body weight gain. Long-term ET-A blockade markedly reduced MAP in HF (−14±3 mm Hg) and NF (−14±2 mm Hg), but it had no effect on HR, GFR, or PRA. These results indicate that a long-term HF diet may cause visceral obesity and increased MAP, even in the absence of major changes in total body weight. Endothelin-1 appears to play an important role in the maintenance of arterial pressure in rats fed HF and NF diets, but it does not appear to contribute to increased MAP in this model of diet-induced hypertension.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/01.HYP.0000111139.94378.74</identifier><identifier>PMID: 14707164</identifier><identifier>CODEN: HPRTDN</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Adipose Tissue - pathology ; Animals ; Arterial hypertension. Arterial hypotension ; Biological and medical sciences ; Blood and lymphatic vessels ; Blood Pressure - drug effects ; Body Weight ; Cardiology. Vascular system ; Clinical manifestations. Epidemiology. Investigative techniques. Etiology ; Eating ; Endothelin A Receptor Antagonists ; Endothelin-1 - physiology ; Experimental diseases ; Fats - administration & dosage ; Heart Rate - drug effects ; Hormones - blood ; Hypertension - etiology ; Hypertension - physiopathology ; Kidney - drug effects ; Kidney - physiopathology ; Male ; Medical sciences ; Obesity - complications ; Obesity - etiology ; Obesity - pathology ; Pyrrolidines - pharmacology ; Rats ; Rats, Sprague-Dawley ; Viscera</subject><ispartof>Hypertension (Dallas, Tex. 1979), 2004-02, Vol.43 (2, Part 2), p.383-387</ispartof><rights>2004 American Heart Association, Inc.</rights><rights>2004 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Feb 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5106-dc94c2cbd1a6535665000d766d2d39bd597c7ed3388e7b597947a0627c085d6f3</citedby><cites>FETCH-LOGICAL-c5106-dc94c2cbd1a6535665000d766d2d39bd597c7ed3388e7b597947a0627c085d6f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15587061$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14707164$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>da Silva, Alexandre A</creatorcontrib><creatorcontrib>Kuo, Jay J</creatorcontrib><creatorcontrib>Tallam, Lakshmi S</creatorcontrib><creatorcontrib>Hall, John E</creatorcontrib><title>Role of Endothelin-1 in Blood Pressure Regulation in a Rat Model of Visceral Obesity and Hypertension</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>ABSTRACT—Endothelial dysfunction has been suggested to play an important role in the development of obesity-induced hypertension. Because endothelin release increases in response to endothelial damage, we examined whether endothelin-1 contributes to increased arterial pressure in a model of visceral obesity produced by feeding Sprague-Dawley rats a high-fat (HF) diet (40% fat w/w, n=6) for 12 months. Arterial and venous catheters were implanted for measurement of mean arterial pressure (MAP) and heart rate (HR) 24 hours per day and intravenous infusions. After a 5-day control period, rats were infused with the selective endothelin-1 type A receptor (ET-A) blocker ABT-627 (2.5 mg/kg per day, IV) for 9 days, followed by a recovery period. Rats fed a standard chow (normal fat, or NF, groupn=6) for 12 months were also infused with ET-A blocker and were used as controls. Compared with NF rats, HF rats had higher MAP (113±4 versus 98±2 mm Hg), increased visceral fat (18.7±2.0 versus 10.8±1.4 g), and 3.2-fold increase in plasma leptin despite similar total body weight gain. Long-term ET-A blockade markedly reduced MAP in HF (−14±3 mm Hg) and NF (−14±2 mm Hg), but it had no effect on HR, GFR, or PRA. These results indicate that a long-term HF diet may cause visceral obesity and increased MAP, even in the absence of major changes in total body weight. Endothelin-1 appears to play an important role in the maintenance of arterial pressure in rats fed HF and NF diets, but it does not appear to contribute to increased MAP in this model of diet-induced hypertension.</description><subject>Adipose Tissue - pathology</subject><subject>Animals</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Blood Pressure - drug effects</subject><subject>Body Weight</subject><subject>Cardiology. Vascular system</subject><subject>Clinical manifestations. Epidemiology. Investigative techniques. Etiology</subject><subject>Eating</subject><subject>Endothelin A Receptor Antagonists</subject><subject>Endothelin-1 - physiology</subject><subject>Experimental diseases</subject><subject>Fats - administration & dosage</subject><subject>Heart Rate - drug effects</subject><subject>Hormones - blood</subject><subject>Hypertension - etiology</subject><subject>Hypertension - physiopathology</subject><subject>Kidney - drug effects</subject><subject>Kidney - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Obesity - complications</subject><subject>Obesity - etiology</subject><subject>Obesity - pathology</subject><subject>Pyrrolidines - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Viscera</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkV9v0zAUxS3ExErhKyBrEntLZjv-k_AG00aRhjZVgODJcuwbmuHGxU409dvjrJUqcV-uLP-O7_E9CF1QUlIq6RWh5erXQ0ly0VxVUza8UnWp-Au0oILxggtZvUQLQhteNJT-PEevU3rMOOdcvULnlCuiqOQLBOvgAYcO3wwujBvw_VBQ3A_4kw_B4YcIKU0R8Bp-T96MfRjmS4PXZsRfgwM_a3_0yUI0Ht-3kPpxj83g8Gq_gzjCkLLmDTrrjE_w9tiX6PvtzbfrVXF3__nL9ce7wgpKZOFswy2zraNGikpIKfIXnZLSMVc1rRONsgpcVdU1qDafGq4MkUxZUgsnu2qJLg_v7mL4O0Ea9Xa25r0ZIExJ14SymnOZwYv_wMcwxSF704wIpmqW97pEHw6QjSGlCJ3exX5r4l5TouckNKE6J6FPSejnJLTiWfzuOGFqt-BO0uPqM_D-CJhkje-iGWyfTpwQtSJydsEP3FPwI8T0x09PEPUGjB83z6M5k3XBcieMUFLMZmT1D06Hn08</recordid><startdate>200402</startdate><enddate>200402</enddate><creator>da Silva, Alexandre A</creator><creator>Kuo, Jay J</creator><creator>Tallam, Lakshmi S</creator><creator>Hall, John E</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>200402</creationdate><title>Role of Endothelin-1 in Blood Pressure Regulation in a Rat Model of Visceral Obesity and Hypertension</title><author>da Silva, Alexandre A ; Kuo, Jay J ; Tallam, Lakshmi S ; Hall, John E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5106-dc94c2cbd1a6535665000d766d2d39bd597c7ed3388e7b597947a0627c085d6f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adipose Tissue - pathology</topic><topic>Animals</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Blood Pressure - drug effects</topic><topic>Body Weight</topic><topic>Cardiology. Vascular system</topic><topic>Clinical manifestations. Epidemiology. Investigative techniques. Etiology</topic><topic>Eating</topic><topic>Endothelin A Receptor Antagonists</topic><topic>Endothelin-1 - physiology</topic><topic>Experimental diseases</topic><topic>Fats - administration & dosage</topic><topic>Heart Rate - drug effects</topic><topic>Hormones - blood</topic><topic>Hypertension - etiology</topic><topic>Hypertension - physiopathology</topic><topic>Kidney - drug effects</topic><topic>Kidney - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Obesity - complications</topic><topic>Obesity - etiology</topic><topic>Obesity - pathology</topic><topic>Pyrrolidines - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Viscera</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>da Silva, Alexandre A</creatorcontrib><creatorcontrib>Kuo, Jay J</creatorcontrib><creatorcontrib>Tallam, Lakshmi S</creatorcontrib><creatorcontrib>Hall, John E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>da Silva, Alexandre A</au><au>Kuo, Jay J</au><au>Tallam, Lakshmi S</au><au>Hall, John E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of Endothelin-1 in Blood Pressure Regulation in a Rat Model of Visceral Obesity and Hypertension</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>2004-02</date><risdate>2004</risdate><volume>43</volume><issue>2, Part 2</issue><spage>383</spage><epage>387</epage><pages>383-387</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><coden>HPRTDN</coden><abstract>ABSTRACT—Endothelial dysfunction has been suggested to play an important role in the development of obesity-induced hypertension. Because endothelin release increases in response to endothelial damage, we examined whether endothelin-1 contributes to increased arterial pressure in a model of visceral obesity produced by feeding Sprague-Dawley rats a high-fat (HF) diet (40% fat w/w, n=6) for 12 months. Arterial and venous catheters were implanted for measurement of mean arterial pressure (MAP) and heart rate (HR) 24 hours per day and intravenous infusions. After a 5-day control period, rats were infused with the selective endothelin-1 type A receptor (ET-A) blocker ABT-627 (2.5 mg/kg per day, IV) for 9 days, followed by a recovery period. Rats fed a standard chow (normal fat, or NF, groupn=6) for 12 months were also infused with ET-A blocker and were used as controls. Compared with NF rats, HF rats had higher MAP (113±4 versus 98±2 mm Hg), increased visceral fat (18.7±2.0 versus 10.8±1.4 g), and 3.2-fold increase in plasma leptin despite similar total body weight gain. Long-term ET-A blockade markedly reduced MAP in HF (−14±3 mm Hg) and NF (−14±2 mm Hg), but it had no effect on HR, GFR, or PRA. These results indicate that a long-term HF diet may cause visceral obesity and increased MAP, even in the absence of major changes in total body weight. Endothelin-1 appears to play an important role in the maintenance of arterial pressure in rats fed HF and NF diets, but it does not appear to contribute to increased MAP in this model of diet-induced hypertension.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>14707164</pmid><doi>10.1161/01.HYP.0000111139.94378.74</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0194-911X |
ispartof | Hypertension (Dallas, Tex. 1979), 2004-02, Vol.43 (2, Part 2), p.383-387 |
issn | 0194-911X 1524-4563 |
language | eng |
recordid | cdi_proquest_miscellaneous_80128446 |
source | MEDLINE; American Heart Association Journals; EZB-FREE-00999 freely available EZB journals; Journals@Ovid Complete |
subjects | Adipose Tissue - pathology Animals Arterial hypertension. Arterial hypotension Biological and medical sciences Blood and lymphatic vessels Blood Pressure - drug effects Body Weight Cardiology. Vascular system Clinical manifestations. Epidemiology. Investigative techniques. Etiology Eating Endothelin A Receptor Antagonists Endothelin-1 - physiology Experimental diseases Fats - administration & dosage Heart Rate - drug effects Hormones - blood Hypertension - etiology Hypertension - physiopathology Kidney - drug effects Kidney - physiopathology Male Medical sciences Obesity - complications Obesity - etiology Obesity - pathology Pyrrolidines - pharmacology Rats Rats, Sprague-Dawley Viscera |
title | Role of Endothelin-1 in Blood Pressure Regulation in a Rat Model of Visceral Obesity and Hypertension |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T17%3A50%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20Endothelin-1%20in%20Blood%20Pressure%20Regulation%20in%20a%20Rat%20Model%20of%20Visceral%20Obesity%20and%20Hypertension&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=da%20Silva,%20Alexandre%20A&rft.date=2004-02&rft.volume=43&rft.issue=2,%20Part%202&rft.spage=383&rft.epage=387&rft.pages=383-387&rft.issn=0194-911X&rft.eissn=1524-4563&rft.coden=HPRTDN&rft_id=info:doi/10.1161/01.HYP.0000111139.94378.74&rft_dat=%3Cproquest_cross%3E80128446%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=205278211&rft_id=info:pmid/14707164&rfr_iscdi=true |